Dr. Michael Stalvey, MD

NPI: 1710085782
Total Payments
$25,389
2023 Payments
$4,761
Companies
12
Transactions
63
Medicare Patients
73
Medicare Billing
$8,105

Payment Breakdown by Category

Consulting$19,921 (78.5%)
Travel$3,337 (13.1%)
Food & Beverage$2,067 (8.1%)
Education$64.54 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $19,921 6 78.5%
Travel and Lodging $3,337 9 13.1%
Food and Beverage $2,067 46 8.1%
Education $64.54 2 0.3%

Top Paying Companies

Company Total Records Latest Year
Vertex Pharmaceuticals Incorporated $14,522 8 $0 (2023)
Endo Pharmaceuticals Inc. $6,057 10 $0 (2019)
Novo Nordisk Inc $2,045 17 $0 (2023)
Novo Nordisk AS $1,253 4 $0 (2019)
TOLMAR Pharmaceuticals, Inc. $850.00 1 $0 (2022)
Medtronic MiniMed, Inc. $223.67 3 $0 (2017)
Ferring Pharmaceuticals Inc. $152.61 12 $0 (2020)
Mylan Specialty L.P. $119.80 1 $0 (2022)
Abbott Laboratories $79.41 4 $0 (2022)
GENZYME CORPORATION $38.19 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $4,761 5 Vertex Pharmaceuticals Incorporated ($3,060)
2022 $1,012 4 TOLMAR Pharmaceuticals, Inc. ($850.00)
2021 $112.56 5 Novo Nordisk Inc ($59.77)
2020 $27.56 2 Novo Nordisk Inc ($14.57)
2019 $7,611 20 Endo Pharmaceuticals Inc. ($5,959)
2018 $6,821 16 Vertex Pharmaceuticals Incorporated ($6,509)
2017 $5,044 11 VERTEX PHARMACEUTICALS INCORPORATED ($4,600)

All Payment Transactions

63 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
05/08/2023 Novo Nordisk Inc Sogroya (Biological) Travel and Lodging In-kind items and services $866.13 General
Category: Growth Hormone
05/08/2023 Novo Nordisk Inc Sogroya (Biological) Travel and Lodging In-kind items and services $411.50 General
Category: Growth Hormone
05/08/2023 Novo Nordisk Inc Sogroya (Biological) Travel and Lodging In-kind items and services $298.70 General
Category: Growth Hormone
05/08/2023 Novo Nordisk Inc Sogroya (Biological) Food and Beverage In-kind items and services $125.08 General
Category: Growth Hormone
01/04/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $3,060.00 General
12/15/2022 Abbott Laboratories FREESTYLE LIBRE (Device) Food and Beverage In-kind items and services $20.11 General
Category: Diabetes Care
11/05/2022 Mylan Specialty L.P. Tobi Podhaler (Drug) Food and Beverage In-kind items and services $119.80 General
Category: Aminoglycosides
08/18/2022 TOLMAR Pharmaceuticals, Inc. FENSOLVI (Drug) Consulting Fee Cash or cash equivalent $850.00 General
Category: Central Precocious Puberty (CPP)
07/13/2022 Abbott Laboratories FREESTYLE LIBRE (Device) Food and Beverage In-kind items and services $22.53 General
Category: Diabetes Care
12/07/2021 Novo Nordisk Inc Norditropin (Biological) Food and Beverage In-kind items and services $44.12 General
Category: Growth Hormone
12/03/2021 Novo Nordisk Inc Norditropin (Biological) Food and Beverage In-kind items and services $15.65 General
Category: Growth Hormone
11/08/2021 Abbott Laboratories FreeStyle Libre (Device) Food and Beverage In-kind items and services $19.59 General
Category: Diabetes Care
09/16/2021 DEXCOM, INC. DEXCOM G6 TRANSMITTER (Device) Food and Beverage In-kind items and services $16.02 General
Category: ENDOCRINOLOGY
07/26/2021 Abbott Laboratories FreeStyle Libre (Device) Food and Beverage In-kind items and services $17.18 General
Category: Diabetes Care
11/20/2020 Novo Nordisk Inc Tresiba (Drug) Food and Beverage In-kind items and services $14.57 General
Category: Diabetes
01/23/2020 Ferring Pharmaceuticals Inc. ZOMACTON (Drug) Food and Beverage In-kind items and services $12.99 General
Category: PEDIATRIC ENDOCRINOLOGY
12/05/2019 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $2.09 General
Category: Diabetes
11/13/2019 Novo Nordisk Inc Tresiba (Drug) Food and Beverage In-kind items and services $4.58 General
Category: Diabetes
11/13/2019 Novo Nordisk Inc Tresiba (Drug) Food and Beverage In-kind items and services $4.58 General
Category: Diabetes
10/29/2019 Endo Pharmaceuticals Inc. SUPPRELIN (Drug) Consulting Fee Cash or cash equivalent $4,810.00 General
Category: ENDOCRINOLOGY
09/21/2019 Endo Pharmaceuticals Inc. SUPPRELIN (Drug) Travel and Lodging In-kind items and services $444.30 General
Category: ENDOCRINOLOGY
09/21/2019 Endo Pharmaceuticals Inc. SUPPRELIN (Drug) Travel and Lodging In-kind items and services $292.67 General
Category: ENDOCRINOLOGY
09/21/2019 Endo Pharmaceuticals Inc. SUPPRELIN (Drug) Food and Beverage In-kind items and services $124.99 General
Category: ENDOCRINOLOGY
09/21/2019 Endo Pharmaceuticals Inc. SUPPRELIN (Drug) Food and Beverage In-kind items and services $86.60 General
Category: ENDOCRINOLOGY
09/21/2019 Endo Pharmaceuticals Inc. SUPPRELIN (Drug) Food and Beverage In-kind items and services $63.60 General
Category: ENDOCRINOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 2 29 39 $7,299 $2,909
2021 2 32 55 $9,856 $4,144
2020 1 12 26 $3,172 $1,053
Total Patients
73
Total Services
120
Medicare Billing
$8,105
Procedure Codes
5

All Medicare Procedures & Services

5 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 16 21 $5,103 $2,083 40.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 13 18 $2,196 $826.25 37.6%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 16 26 $6,318 $2,649 41.9%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 16 29 $3,538 $1,494 42.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 12 26 $3,172 $1,053 33.2%

About Dr. Michael Stalvey, MD

Dr. Michael Stalvey, MD is a Pediatric Endocrinology healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710085782.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Stalvey, MD has received a total of $25,389 in payments from pharmaceutical and medical device companies, with $4,761 received in 2023. These payments were reported across 63 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($19,921).

As a Medicare-enrolled provider, Stalvey has provided services to 73 Medicare beneficiaries, totaling 120 services with total Medicare billing of $8,105. Data is available for 3 years (2020–2022), covering 5 distinct procedure/service records.

Practice Information

  • Specialty Pediatric Endocrinology
  • Location Winston Salem, NC
  • Active Since 09/21/2006
  • Last Updated 02/16/2023
  • Taxonomy Code 2080P0205X
  • Entity Type Individual
  • NPI Number 1710085782

Products in Payments

  • KALYDECO (Drug) $6,248
  • SUPPRELIN (Drug) $5,959
  • Sogroya (Biological) $1,701
  • FENSOLVI (Drug) $850.00
  • ZOMACTON (Drug) $152.61
  • Norditropin (Drug) $120.97
  • Minimed 670G System (Device) $120.55
  • Tobi Podhaler (Drug) $119.80
  • Minimed 530G (Device) $103.12
  • SUPPRELIN LA (Drug) $97.87
  • Norditropin (Biological) $59.77
  • FREESTYLE LIBRE (Device) $42.64
  • MPS I-DISEASE (Drug) $38.19
  • FreeStyle Libre (Device) $36.77
  • Tresiba (Drug) $36.72
  • HUMATROPE (Drug) $32.80
  • DEXCOM G6 TRANSMITTER (Device) $16.02
  • FIASP (Drug) $12.61
  • Ozempic (Drug) $2.09

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Endocrinology Doctors in Winston Salem